SCHEMBL2490178

SCHEMBL2490178

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.38
BRD2 P25440 1/20 0.38
ESR2 Q92731 1/20 0.38
PTGS1 P23219 2/20 0.37
PTGS2 P35354 2/20 0.37
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
CYP2A6 P11509 1/20 0.36
CYP2B6 P20813 1/20 0.36
MEN1 O00255 2/20 0.35
NPC1 O15118 2/20 0.35
KMT2A Q03164 2/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
HSP90AB1 P08238 1/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10484543 0.82 PDCD1 (0.47) BRD4BRD2ESR2PTGS1PTGS2
SCHEMBL5764423 0.81 BRD4 (0.39) BRD4BRD2PTGS1PTGS2CYP2A6
SCHEMBL4870784 0.80 LMNA (0.39) BRD4BRD2ESR2PTGS1PTGS2
SCHEMBL4473038 0.78 TDP2 (0.46) BRD4BRD2ESR2PTGS1PTGS2
SCHEMBL21616555 0.78 PTGS1 (0.40) BRD4BRD2PTGS1PTGS2CYP2A6
SCHEMBL1009932 0.75 HSD17B10 (0.46) BRD4ESR2PDCD1CD274CYP2A6
SCHEMBL2489466 0.75 ALOX5AP (0.35) PTGS1PTGS2CYP2A6MEN1NPC1
SCHEMBL2199424 0.75 BACE1 (0.48) ESR2PDCD1CD274HSP90AB1MAPT
SCHEMBL15856372 0.75 PTGS2 (0.39) ESR2PTGS1PTGS2PDCD1CD274
SCHEMBL2492329 0.75 HDAC4 (0.45) ESR2HSP90AB1LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH BRD4 1897/4885BRD2 2679/4885ESR2 3511/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 BRD4 2085/4885BRD2 2776/4885ESR2 3465/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R BRD4 2038/4885BRD2 2798/4885ESR2 3449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.